0.0195
74.11%
0.0083
Nls Pharmaceutics Ag Stock (NLSPW) Forecast
The Nls Pharmaceutics Ag (NLSPW) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0476, representing a +144.27% increase from the current price of $0.0195. The highest analyst price target is $0.0799, and the lowest is $0.0154.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NLSPW Price Target
Average 0.089
(+356.54% Upside)
Is Nls Pharmaceutics Ag (NLSPW) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 59.12 | Neutral |
STOCH(9,6) | 55.80 | Neutral |
STOCHRSI(14) | 86.92 | Sell |
MACD(12,26) | 0.000453 | Buy |
ADX(14) | 42.25 | Buy |
William %R | 0.00 | Sell |
CCI(14) | 123.84 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
0.0109
Buy
|
0.0126
Buy
|
MA20 |
0.0104
Buy
|
0.0116
Buy
|
MA50 |
0.0121
Buy
|
0.0138
Buy
|
MA100 |
0.0213
Sell
|
0.0202
Sell
|
MA200 |
0.0252
Sell
|
0.00
Buy
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, NLSPW could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on NLSPW, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.12 indicates that NLSPW is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.8 indicates that NLSPW is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 86.92 indicates that NLSPW is oversold. This suggests that NLSPW price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 42.25 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 123.84 indicates that NLSPW is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term NLSPW price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nls Pharmaceutics Ag financial reports and earnings history, Nls Pharmaceutics Ag (NLSPW) stock could reach $0.4218 by 2030, $1.2778 by 2040 and $2.1338 by 2050. See the projected annual prices until 2050 of the Nls Pharmaceutics Ag stock below:
- Nls Pharmaceutics Ag (NLSPW) is expected to reach an average price of $1.4036 in 2035, with a high prediction of $1.4806 and a low estimate of $0.1403. This indicates an $7,098% rise from the last recorded price of $0.0195.
- Nls Pharmaceutics Ag (NLSPW) stock is projected to chart a bullish course in 2040, with an average price target of $0.91, representing an $4,566% surge from its current level. The forecast ranges from a conservative $0.945 to a sky-high $1.2778.
- Our analysts predict Nls Pharmaceutics Ag (NLSPW) to jump 13,882% by 2045, soaring from $0.2959 to an average price of $2.7265, potentially reaching $2.8813. While $0.2959 is the low estimate, the potential upside is significant.
- Nls Pharmaceutics Ag (NLSPW) stock is expected to climb by 2050, reaching an average of $1.5325, a $7,759% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.1338 and $1.5675, respectively, highlighting the market's uncertainty.
Nls Pharmaceutics Ag Stock (NLSPW) Year by Year Forecast
Nls Pharmaceutics Ag Stock (NLSPW) Price Forecast for 2025
Nls Pharmaceutics Ag Stock (NLSPW) is expected to reach an average price of $0.089 in 2025, with a high prediction of $0.1765 and a low estimate of $0.00155. This indicates an +356.54% rise from the last recorded price of $0.0195.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $0.0588 | $0.0154 | $0.0799 | +201.54% |
February, 2025 | $0.0366 | $0.0397 | $0.0347 | +87.93% |
March, 2025 | $0.0131 | $0.0219 | $0.0184 | -32.82% |
April, 2025 | $0.0023 | $0.0024 | $0.0396 | -88.21% |
May, 2025 | $0.1264 | $0.00155 | $0.1282 | +548.03% |
June, 2025 | $0.0745 | $0.0745 | $0.1017 | +282.22% |
July, 2025 | $0.00837 | $0.0434 | $0.0381 | -57.09% |
August, 2025 | $0.013 | $0.0131 | $0.0261 | -33.16% |
September, 2025 | $0.1932 | $0.00463 | $0.1765 | +890.77% |
October, 2025 | $0.1094 | $0.1094 | $0.1447 | +461.11% |
November, 2025 | $0.057 | $0.0708 | $0.0676 | +192.31% |
December, 2025 | $0.0312 | $0.0421 | $0.0315 | +60.17% |
Nls Pharmaceutics Ag Stock (NLSPW) Price Forecast for 2026
The predicted value for Nls Pharmaceutics Ag (NLSPW) in 2026 is set at an average of $0.1611. Estimates vary from a peak of $0.3214 to a trough of $0.000733, indicating an +725.98% surge from the present price of $0.0195.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $0.2415 | $0.000733 | $0.2248 | +1,138% |
February, 2026 | $0.1703 | $0.1703 | $0.1876 | +773.33% |
March, 2026 | $0.121 | $0.121 | $0.1393 | +520.51% |
April, 2026 | $0.0446 | $0.0555 | $0.08 | +128.97% |
May, 2026 | $0.0203 | $0.0061 | $0.0344 | +3.85% |
June, 2026 | $0.2218 | $0.226 | $0.2731 | +1,037% |
July, 2026 | $0.1478 | $0.1478 | $0.1742 | +658.12% |
August, 2026 | $0.0637 | $0.0927 | $0.1042 | +226.67% |
September, 2026 | $0.00143 | $0.0115 | $0.0451 | -92.65% |
October, 2026 | $0.262 | $0.2662 | $0.3214 | +1,244% |
November, 2026 | $0.1873 | $0.1938 | $0.2091 | +860.68% |
December, 2026 | $0.0798 | $0.1088 | $0.1283 | +309.23% |
Nls Pharmaceutics Ag Stock (NLSPW) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nls Pharmaceutics Ag (NLSPW) is $0.2416, with a high forecast of $0.4663 and a low forecast of $0.0168. This indicates an +1,139% increase from the last price of $0.0195.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $0.00393 | $0.0168 | $0.0559 | -79.83% |
February, 2027 | $0.3164 | $0.3313 | $0.3697 | +1,523% |
March, 2027 | $0.2298 | $0.2487 | $0.2621 | +1,079% |
April, 2027 | $0.139 | $0.1507 | $0.1857 | +612.56% |
May, 2027 | $0.0464 | $0.0468 | $0.0959 | +137.69% |
June, 2027 | $0.4001 | $0.0222 | $0.418 | +1,952% |
July, 2027 | $0.262 | $0.2809 | $0.3593 | +1,244% |
August, 2027 | $0.1372 | $0.1722 | $0.2152 | +603.42% |
September, 2027 | $0.0544 | $0.0548 | $0.112 | +178.97% |
October, 2027 | $0.4457 | $0.0276 | $0.4663 | +2,186% |
November, 2027 | $0.3187 | $0.3187 | $0.4023 | +1,534% |
December, 2027 | $0.1586 | $0.1936 | $0.2542 | +713.50% |
Nls Pharmaceutics Ag Stock (NLSPW) Price Forecast for 2028
In 2028, Nls Pharmaceutics Ag (NLSPW) is projected to reach an average price of $0.3221, with a high projection of $0.6112 and a low estimate of $0.0329. This indicates an +1,552% rise from the last price of $0.0195.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $0.0882 | $0.0883 | $0.1281 | +352.14% |
February, 2028 | $0.5313 | $0.0329 | $0.5146 | +2,625% |
March, 2028 | $0.3536 | $0.3536 | $0.4475 | +1,713% |
April, 2028 | $0.2261 | $0.2398 | $0.2864 | +1,059% |
May, 2028 | $0.1251 | $0.136 | $0.1801 | +541.79% |
June, 2028 | $0.5796 | $0.0383 | $0.5629 | +2,872% |
July, 2028 | $0.4333 | $0.4333 | $0.4931 | +2,122% |
August, 2028 | $0.2502 | $0.264 | $0.3835 | +1,183% |
September, 2028 | $0.1386 | $0.1494 | $0.2016 | +610.59% |
October, 2028 | $0.0766 | $0.0437 | $0.1095 | +292.82% |
November, 2028 | $0.4708 | $0.4708 | $0.6112 | +2,315% |
December, 2028 | $0.3357 | $0.3357 | $0.4184 | +1,621% |
Nls Pharmaceutics Ag Stock (NLSPW) Price Forecast for 2029
The 2029 price forecast for Nls Pharmaceutics Ag Stock (NLSPW) is $0.4026 on average, with a high prediction of $0.7561 and a low estimate of $0.049. This represents an +1,964% increase from the previous price of $0.0195.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $0.1764 | $0.2054 | $0.2732 | +804.62% |
February, 2029 | $0.0361 | $0.049 | $0.1203 | +85.30% |
March, 2029 | $0.5438 | $0.548 | $0.6595 | +2,688% |
April, 2029 | $0.394 | $0.4005 | $0.4635 | +1,920% |
May, 2029 | $0.1925 | $0.2215 | $0.3036 | +887.18% |
June, 2029 | $0.0415 | $0.0544 | $0.131 | +112.82% |
July, 2029 | $0.6169 | $0.6318 | $0.7078 | +3,064% |
August, 2029 | $0.4235 | $0.43 | $0.5439 | +2,072% |
September, 2029 | $0.2704 | $0.2895 | $0.3304 | +1,287% |
October, 2029 | $0.1027 | $0.1031 | $0.2086 | +426.67% |
November, 2029 | $0.6599 | $0.0598 | $0.7561 | +3,284% |
December, 2029 | $0.4874 | $0.5063 | $0.5841 | +2,400% |
Nls Pharmaceutics Ag Stock (NLSPW) Price Forecast for 2030
Nls Pharmaceutics Ag Stock (NLSPW) is expected to reach an average price of $0.4831 in 2030, with a high forecast of $0.901 and a low forecast of $0.0651. This signifies an +2,377% surge from the last price of $0.0195.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $0.2892 | $0.3083 | $0.4218 | +1,383% |
February, 2030 | $0.1108 | $0.1112 | $0.2247 | +467.95% |
March, 2030 | $0.765 | $0.0651 | $0.8044 | +3,823% |
April, 2030 | $0.5629 | $0.5629 | $0.7028 | +2,787% |
May, 2030 | $0.3089 | $0.3439 | $0.4796 | +1,484% |
June, 2030 | $0.1633 | $0.1634 | $0.2493 | +737.44% |
July, 2030 | $0.8694 | $0.0705 | $0.8527 | +4,358% |
August, 2030 | $0.5978 | $0.5978 | $0.7668 | +2,966% |
September, 2030 | $0.3951 | $0.4089 | $0.5118 | +1,926% |
October, 2030 | $0.174 | $0.1741 | $0.3304 | +792.48% |
November, 2030 | $0.9177 | $0.0759 | $0.901 | +4,606% |
December, 2030 | $0.6962 | $0.6962 | $0.8124 | +3,470% |
Cap:
|
Volume (24h):